Copyright
©2014 Baishideng Publishing Group Inc.
World J Cardiol. Jul 26, 2014; 6(7): 621-629
Published online Jul 26, 2014. doi: 10.4330/wjc.v6.i7.621
Published online Jul 26, 2014. doi: 10.4330/wjc.v6.i7.621
Table 2 Specific recommendations on the treatment of chronic total occlusion in the American and European Practice Guidelines
Society | Guideline | Specific recommendation on the treatment of CTO |
EUROPEAN | 2010 Guidelines of myocardial revascularization[9] | “Revascularization of CTO may be considered in the presence of angina or ischemia related to the corresponding territory” |
2013 ESC guidelines on the management of stable coronary artery disease[1] | “Revascularization needs to be discussed in patients with symptoms of occlusion or large ischemic areas” | |
AMERICAN | 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery[10] | Not mentioned |
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention[11] | Recommendation IIa. Evidence level B. PCI of a CTO in patients with appropriate clinical indications and suitable anatomy is reasonable when performed by operators with appropriate expertise “The decision to try PCI for a CTO (vs continued medical therapy or surgical revascularization) requires an individualized risk-benefit analysis encompassing clinical, angiographic, and technical considerations” | |
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease[12] | Not mentioned |
- Citation: Bardají A, Rodriguez-López J, Torres-Sánchez M. Chronic total occlusion: To treat or not to treat. World J Cardiol 2014; 6(7): 621-629
- URL: https://www.wjgnet.com/1949-8462/full/v6/i7/621.htm
- DOI: https://dx.doi.org/10.4330/wjc.v6.i7.621